Rhythm Pharmaceuticals

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome.

Morgan Prestwich continue to be partner of choice for all their international appointments. Positions we have successfully appointed to date are:

Country-leadership:
- General Manager - Spain
- General Manager - Germany
- General Manager - UK
- Country Manager - Belgium

Additional positions:
- Medical Directors - Germany, France, UK, Spain, Italy
- European Marketing Director
- MSL's - Germany, France and Spain
- KAM's - various countries across Europe